secwatch / observer
8-K filed August 22, 2023, 7:59 PM ET ticker VIVS CIK 0001497253
leadership confidence high sentiment negative materiality 0.75

VivoSim Labs, INC. (VIVS): restructuring charge — Organovo reduces workforce by 24% and terminates General Counsel and CSO to focus on FXR314

VivoSim Labs, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tom Jurgensen

General Counsel and Corporate Secretary
VIVS · VivoSim Labs, INC.
Effective
2023-08-25
Filed
August 22, 2023, 7:59 PM ET
on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.
Departed

Jeffrey Miner

Chief Scientific Officer
VIVS · VivoSim Labs, INC.
Effective
2023-08-25
Filed
August 22, 2023, 7:59 PM ET
on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Jurgensen was terminated as General Counsel and Corporate Secretary at VivoSim Labs, INC..

Action
terminated
Role
General Counsel and Corporate Secretary
Exact text from the filing
on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Miner was terminated as Chief Scientific Officer at VivoSim Labs, INC..

Action
terminated
Role
Chief Scientific Officer
Exact text from the filing
on August 16, 2023, Tom Jurgensen, the Company’s General Counsel and Corporate Secretary, and Jeffrey Miner, the Company’s Chief Scientific Officer, were each notified that his employment with the Company would be terminated.
View on SEC.gov
Restructurings & Charges SEC 8-K Item 2.05/2.06 confidence 0.9

VivoSim Labs, INC. announced a restructuring (approximately six employees, which represents approximately 24% of its employees as of August 18, 2023).

Type
restructuring
Headcount
approximately six employees, which represents approximately 24% of its employees as of August 18, 2023
Exact text from the filing
On August 18, 2023, Organovo Holdings, Inc. (the “Company”) announced to its employees a plan to reduce the Company’s workforce, effective August 25, 2023, by approximately six employees, which represents approximately 24% of its employees as of August 18, 2023.
View on SEC.gov

Browse all restructurings & charges →

VivoSim Labs, INC. filing history →

Source: SEC EDGAR
accession 0001193125-23-218056
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.